HNGE is the ticker symbol for Hinge Health, Inc., a publicly traded Technology sector company listed on NYSE. 13F Pro tracks HNGE with AI-powered analysis, an AI quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is HNGE a good stock to buy?

13F Pro's AI ranking engine scores HNGE at 75.3/100, ranked #95 of 2,925 stocks on a composite quality score built from its SEC filings, covering profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for HNGE is available at https://13fpro.ai/company/HNGE. Not investment advice — review the underlying SEC filings before making any trade.

Where does 13F Pro source HNGE data?

All Hinge Health, Inc. fundamentals and ownership data come directly from SEC EDGAR. Hinge Health, Inc. files with the SEC under CIK 1673743. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

Hinge Health, Inc. HNGE

NYSEMid CapTechnology

13F Pro quality score

Rank #95 of 2,925TOP 5%

Why it scores 75 Technology peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$212.82M

Quarter to Jun 30

Net income

$43.69M

Quarter to Jun 30

Free cash flow

$101.29M

Quarter to Jun 30

Operating margin

19.0%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026

$4.77B total

BlackRock, Inc.

$296.32M+293.4%

11.2 Capital Management, LLC

$204.57M-33.5%

VANGUARD PORTFOLIO MANAGEMENT LLC

$178.12M+52.1%

Deer Management Co. LLC

$158.42M-27.5%

VANGUARD CAPITAL MANAGEMENT LLC

$157.11M+52.8%

TWO SIGMA INVESTMENTS, LP

$150.06M+371.0%

FULLER & THALER ASSET MANAGEMENT, INC.

$142.14M+3.5%

MORGAN STANLEY

$133.95M+63.1%

FRANKLIN RESOURCES INC

$131.06M+64.7%

JANE STREET GROUP, LLC

$117.72M+154.6%

BRAIDWELL LP

$110.40M-8.6%

Divisadero Street Capital Management, LP

$107.12M+126.2%

Walleye Capital LLC

$105.21M+1086.4%

WELLINGTON MANAGEMENT GROUP LLP

$100.06M+169.7%

BIT Capital GmbH

$95.88M-50.0%

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

$92.87M-3.8%

BAMCO INC /NY/

$92.77M-1.1%

ACADIAN ASSET MANAGEMENT LLC

$88.11M+181.4%

MARSHALL WACE, LLP

$87.34M+262.3%

GOLDMAN SACHS GROUP INC

$83.93M+249.9%

STATE STREET CORP

$79.70M+609.5%

GEODE CAPITAL MANAGEMENT, LLC

$75.84M+405.3%

OBERWEIS ASSET MANAGEMENT INC/

$71.00M+83.7%

BNP PARIBAS FINANCIAL MARKETS

$70.64M+69.5%

VOYA INVESTMENT MANAGEMENT LLC

$64.59MNew

See all 279 institutional holders →

What's Driving HNGE's Business? Latest 10-Q Breakdown

43/43 datapoints verified

AI-extracted from the 10-Q filed 2026-08-06 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Q2 revenue rose 53% to $212.8M with gross margin up 16 points to 86%, producing $43.7M net income versus a $575.7M IPO-charge loss a year ago.

Biggest Revenue Drivers

Member subscription revenue (one reportable segment)$212.8M+53% YoY

Increase primarily due to revenue growth from existing clients, from retaining members within and adding more members to the existing member base

Biggest Revenue Drivers

Total revenue: $212.8M+53% YoY

Member subscription revenue (one reportable segment)$212.8M+53% YoY

Increase primarily due to revenue growth from existing clients, from retaining members within and adding more members to the existing member base

Within Member subscription revenue (one reportable segment)

Recognized from beginning-of-period deferred revenue$171.2M

Revenue recognized during the quarter that was included in the deferred revenue balance at the beginning of the period

Largest Expense Items

Sales and marketing$81.4M-45% YoY

$89.1M lower stock-based compensation tied to IPO vesting, offset by $13.3M more marketing and promotion and $9.5M more commissions

Research and development$34.1M-88% YoY

$241.7M decrease in stock-based compensation from RSU/PRSU vesting criteria met at the 2025 IPO, offset by $1.8M higher IT costs

Cost of revenue$28.9M-30% YoY

$15.3M lower stock-based compensation, partly offset by $2.9M higher inventory costs (net of a $1.7M tariff refund) and $1.4M hosting

General and administrative$28.0M-89% YoY

$225.8M lower stock-based compensation, offset by $4.5M higher legal and other costs supporting public company compliance

Margins: Gross margin rose 16 percentage points to 86% from 70%, primarily due to lower stock-based compensation and greater care team operating efficiencies. Non-GAAP operating margin reached 29% versus 19%.

Watch Items from the Filing

Partner concentration: contracts through partners were 85% of six-month revenue; HCSC 15%, Elevance 13%, Aetna 10%. Partners are non-exclusive and may terminate for convenience.
Deferred revenue grew to $416.5M from $300.9M at year-end, and LTM calculated billings reached $861.8M versus $568.4M a year earlier.
Announced August 4, 2026 definitive agreement to acquire Cylinder Health for $105 million cash, expected to close in the third quarter of 2026.
Founder PRSU settlements triggered roughly $37.9M and $39.6M of company cash outlays for tax withholding in the third quarter of 2026.
Repurchased $196.5M of Class A stock through July 29, 2026; board raised total authorization to $496.5M, with $300.0M remaining available.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →

Key Metrics

Revenue

Q2 2026

EDGAR

Net Income

Q2 2026

EDGAR

EPS (Diluted)

Q2 2026

EDGAR

Operating Margin

Q2 2026

EDGAR

ROIC

Q2 2026

EDGAR

Free Cash Flow

Q2 2026

EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/HNGE

Earnings Per Share

13fpro.ai/company/HNGE

Loading ratio trend…

Hinge Health, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Op. marginOperating margin
FY 2025	10-K	$587.9M	$-528.3M	-92.9%
FY 2024	10-K	$390.4M	$-11.9M	-8.2%
FY 2023	10-K	$292.7M	$-108.1M	-44.6%

About Hinge Health, Inc. (HNGE): stock profile, AI score and financials

Hinge Health, Inc. (HNGE) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores HNGE at 75.3/100 on a composite quality score built from its SEC filings, placing it at rank #95 of 2,925 stocks — the top 5% of the AI-ranked universe. HNGE scores in the top quartile across balance sheet strength (92.3), free cash flow (91.3), revenue growth (87.5). Shareholder dilution risk is elevated at 2.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Hinge Health, Inc. reports quarterly revenue of $212.8M, net income of $43.7M, an operating margin of 19.0%. Top institutional holders of HNGE by reported 13-F value include BlackRock, 11.2 Capital Management, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. HNGE trades on the NYSE exchange and files with the SEC under CIK 1673743. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HNGE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Hinge Health, Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1673743 →

Hinge Health, Inc. HNGE

Top Institutional Holders

What's Driving HNGE's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Biggest Revenue Drivers

Largest Expense Items

Watch Items from the Filing

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

HNGE key financials by period

HNGE insiders

About Hinge Health, Inc. (HNGE): stock profile, AI score and financials

Hinge Health, Inc. HNGE

Top Institutional Holders

What's Driving HNGE's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

HNGE key financials by period

Companies similar to HNGE

HNGE insiders

About Hinge Health, Inc. (HNGE): stock profile, AI score and financials